Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display - Cocktail

387 - Prognosis of Three Histological Subtypes of Colorectal Adenocarcinoma: A Retrospective Analysis of 8005 Chinese Patients


24 Nov 2018


Poster display - Cocktail


Pathology/Molecular Biology

Tumour Site

Colon and Rectal Cancer


Chao Li


Annals of Oncology (2018) 29 (suppl_9): ix28-ix45. 10.1093/annonc/mdy431


C. Li1, H. Zheng2, D. Huang3, S. Cai2, J. Zhu1

Author affiliations

  • 1 Radiation Oncology, Shanghai Cancer Center Fudan University, 200032 - Shanghai/CN
  • 2 Colorectal Surgery, Shanghai Cancer Center Fudan University, 200032 - Shanghai/CN
  • 3 Department Of Pathology, Shanghai Cancer Center Fudan University, 200032 - Shanghai/CN


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 387


To evaluate the effect of the varied histological subtypes on clinical outcome and to determine the prognostic implications of mucinous adenocarcinoma (MAC) and signet ring cell carcinoma (SRCC) compared with common adenocarcinoma (AC).


A total of 9015 patients with colorectal adenocarcinoma undergoing definitive surgery between 2007 and 2015 at FUSCC were enrolled in this study. After 1010 of these patients were excluded because of neoadjuvant therapy, 8005, including 7502 AC, 428 MAC and 75 SRCC, remained for analysis, where clinical, histopathological, and survival data were analyzed.


MAC and SRCC were more common in right-sided colon cancer together with male or young patients, compared to AC, with a higher probability to develop lymph node metastasis, lymphovascular invasion and perineural invasion. As for survival outcomes, we found that the 5-year OS of SRCC was significantly lower than that of MAC and AC, while the 5-year OS of MAC is much lower than that of AC. However, in multivariable analysis, the difference in survival between SRCC, MAC and AC was no longer significant, especially when stratified by N stage.


MAC and SRCC are rare subtypes of colorectal cancer with a higher T stage, N stage as well as higher invasion ability. However, neither MAC or SRCC was an independent predictor of decreased survival in multivariate analysis.

Editorial acknowledgement

Clinical trial identification

Legal entity responsible for the study

Shanghai Cancer Center Fudan University.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.